Worth Rs.1292 FabiFlu 34 Tablet at Rs.1098. Favipiravir is an antiviral drug approved by the DCGI of India for the treatment of Mild to moderate COVID -19 disease. This medicine has been approved for use under restricted emergency and is not to be used without proper approval from the healthcare professional. It is recommended for the patient to fill out an informed consent form before receiving this medicine for the treatment for COVID -19 disease.